131 related articles for article (PubMed ID: 11558704)
1. Medical R&D at the turn of the millennium.
Zinner DE
Health Aff (Millwood); 2001; 20(5):202-9. PubMed ID: 11558704
[No Abstract] [Full Text] [Related]
2. CTSA program continues 'on track' despite backlog.
Samson K
Ann Neurol; 2009 Sep; 66(3):A9-13. PubMed ID: 19810089
[No Abstract] [Full Text] [Related]
3. The role of the private sector in biotechnology: research and development.
Feisee L
Health Matrix Clevel; 2002; 12(2):357-65. PubMed ID: 12430359
[No Abstract] [Full Text] [Related]
4. Innovative antibody research and development (R&D) is the vanguard of a variety of science, technology, and medical fields that require substantial investment of both time and money.
Reichert JM
MAbs; 2009; 1(2):91-2. PubMed ID: 20061823
[No Abstract] [Full Text] [Related]
5. Biomedical research in an age of austerity.
Moses H; Dorsey ER
JAMA; 2012 Dec; 308(22):2341-2. PubMed ID: 23240142
[No Abstract] [Full Text] [Related]
6. The NIH budget and the future of biomedical research.
Loscalzo J
N Engl J Med; 2006 Apr; 354(16):1665-7. PubMed ID: 16625006
[No Abstract] [Full Text] [Related]
7. Biomedical research in an era of unlimited aspirations and limited resources.
Fauci AS
Lancet; 1996 Oct; 348(9033):1002-3. PubMed ID: 8855860
[No Abstract] [Full Text] [Related]
8. Research for hire.
Serafini MW
Natl J (Wash); 1996 Mar; 28(13):704-8. PubMed ID: 10155831
[No Abstract] [Full Text] [Related]
9. Who will fund the next medical breakthrough?
Maguire P
Manag Care; 1998 May; 7(5):27-8, 31-4. PubMed ID: 10180137
[No Abstract] [Full Text] [Related]
10. University, industry, and governmental consortia: alliances for a new era.
Moskowitz J
Ann Thorac Surg; 1997 Sep; 64(3):906-7. PubMed ID: 9307517
[No Abstract] [Full Text] [Related]
11. Stat bite: NCI R01 success rates, 1970-2005.
J Natl Cancer Inst; 2006 Oct; 98(20):1437. PubMed ID: 17047188
[No Abstract] [Full Text] [Related]
12. Regulating scientific research: intellectual property rights and the norms of science.
Rai AK
Northwest Univ Law Rev; 1999; 94(1):77-152. PubMed ID: 12784815
[No Abstract] [Full Text] [Related]
13. Stat bite: NIH, NCI appropriations, 1997-2007.
J Natl Cancer Inst; 2006 Mar; 98(6):376. PubMed ID: 16537826
[No Abstract] [Full Text] [Related]
14. The essentiality of biomedical research.
Glaser RJ
Pharos Alpha Omega Alpha Honor Med Soc; 1995; 58(4):33. PubMed ID: 8539276
[No Abstract] [Full Text] [Related]
15. NIH, related agencies face flat budget future.
Finkelstein JB
J Natl Cancer Inst; 2006 Mar; 98(6):376-7. PubMed ID: 16537827
[No Abstract] [Full Text] [Related]
16. Opportunities lost: NIH research funding to New York's medical schools.
Sturman LS; Sorin MD; Hannum RJ
J Urban Health; 2000 Mar; 77(1):86-95. PubMed ID: 10741844
[No Abstract] [Full Text] [Related]
17. Addressing the decline in NIH pain research funding.
Max MB
J Pain; 2008 Dec; 9(12):1074-6. PubMed ID: 19038769
[No Abstract] [Full Text] [Related]
18. Funding health sciences research: a strategy to restore balance.
Bloom FE; Bulger RE; Randolph MA
Clin Res; 1990 Dec; 38(4):671-85. PubMed ID: 2177388
[No Abstract] [Full Text] [Related]
19. Increasing R01 competition concerns researchers.
Vastag B
J Natl Cancer Inst; 2006 Oct; 98(20):1436-8. PubMed ID: 17047187
[No Abstract] [Full Text] [Related]
20. Academic medical research: will collaboration with industry and national laboratories save it?
Eaton RP
Pharos Alpha Omega Alpha Honor Med Soc; 1995; 58(4):2-4. PubMed ID: 8539272
[No Abstract] [Full Text] [Related]
[Next] [New Search]
